BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17441261)

  • 1. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 2. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 4. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk.
    Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of hs-CRP measurements in the current cardiovascular risk assessment.
    García-Moll X; Ordóñez-Llanos J
    Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499
    [No Abstract]   [Full Text] [Related]  

  • 6. [The revival of an old diagnostic marker: C-reactive protein].
    Sela B
    Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Or are we putting the cart before the horse?
    Wong ND
    Prev Cardiol; 2010; 13(4):149-51. PubMed ID: 20860636
    [No Abstract]   [Full Text] [Related]  

  • 10. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
    Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
    Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
    Biasucci LM
    Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
    [No Abstract]   [Full Text] [Related]  

  • 12. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
    Maseri A
    Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of high-sensitivity C-reactive protein].
    Ueno H
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():137-41. PubMed ID: 16983765
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
    May A; Wang TJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple biomarkers for predicting cardiovascular events: lessons learned.
    Wang TJ
    J Am Coll Cardiol; 2010 May; 55(19):2092-5. PubMed ID: 20447531
    [No Abstract]   [Full Text] [Related]  

  • 16. [CRP--a marker of a pro-inflammatory state and cardiovascular risk].
    Poledne R; Valenta Z; Pit'ha J
    Vnitr Lek; 2007 Apr; 53(4):391-5. PubMed ID: 17578172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting benefit from statins by C-reactive protein, LDL-cholesterol or absolute cardiovascular risk.
    Stewart RA
    Future Cardiol; 2009 May; 5(3):231-6. PubMed ID: 19656039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
    Sinning C; Keller T; Blankenberg S
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2019-22. PubMed ID: 19777420
    [No Abstract]   [Full Text] [Related]  

  • 19. [C-reactive protein--a molecule that changed cardiology].
    Ostádal P
    Vnitr Lek; 2004 Nov; 50(11):809-11. PubMed ID: 15648958
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond cholesterol. Inflammation is emerging as a major risk factor--and not just in heart disease.
    Park A
    Time; 2002 Nov; 160(22):74-5. PubMed ID: 12463072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.